Pro Share Advisors LLC Xenon Pharmaceuticals Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$42.66 - $50.04 $24,102 - $28,272
565 Added 11.97%
5,286 $227,000
Q4 2023

Feb 14, 2024
BUY
$28.7 - $46.46 $135,492 - $219,337
4,721 New
4,721 $217,000
Q4 2022

Feb 02, 2023
BUY
$33.06 - $39.43 $170,986 - $203,931
5,172 New
5,172 $203,000
Q1 2022

May 10, 2022
SELL
$25.09 - $33.13 $182,303 - $240,722
-7,266 Closed
0 $0
Q4 2021

Feb 08, 2022
BUY
$15.6 - $35.4 $113,349 - $257,216
7,266 New
7,266 $227,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email